Characterization of the Lipid Metabolism in Bladder Cancer to Guide Clinical Therapy

Figure 7

Drug response to chemotherapy or immunotherapy for bladder cancer of high- and low-risk score patients. (a) Chemotherapy drug sensitivity in high- and low-risk score patients. (b) Metformin sensitivity in high- and low-risk score patients. (c) Potential response to immunotherapy in high- and low-risk score groups. The y-axis means the sensitivity of these drugs, and the unit is IC50 (50% inhibiting concentration).

(a)

(b)

(c)